XTANT MEDICAL HOLDINGS, INC. Stock or Unit Option Plan Expense
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Stock or Unit Option Plan Expense of $127.11 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-04-05.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:StockOptionPlanExpense · last filed 2018-04-05
- XTANT MEDICAL HOLDINGS, INC. stock or unit option plan expense for the quarter ending 2012-09-30 was $433.51K, a 32.37% increase year-over-year.
- XTANT MEDICAL HOLDINGS, INC. stock or unit option plan expense for the quarter ending 2011-09-30 was $327.50K.
- XTANT MEDICAL HOLDINGS, INC. stock or unit option plan expense for fiscal 2017 was $127.11K, a 42.55% decline from fiscal 2016.
- XTANT MEDICAL HOLDINGS, INC. stock or unit option plan expense for fiscal 2016 was $221.26K.
| Period end | Stock or Unit Option Plan Expense 3 month | Stock or Unit Option Plan Expense 6 month | Stock or Unit Option Plan Expense 9 month | Stock or Unit Option Plan Expense 12 month |
|---|---|---|---|---|
| 2017-12-31 | $127.11K 10-K · filed 2018-04-05 | |||
| 2016-12-31 | $221.26K 10-K · filed 2018-04-05 | |||
| 2012-09-30 | $433.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $623.57K 10-Q · filed 2012-11-08 | ||
| 2012-06-30 | $190.06K 10-Q · filed 2012-08-10 | |||
| 2011-09-30 | $327.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $708.70K 10-Q · filed 2012-11-08 | ||
| 2011-06-30 | $381.20K 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |